Theresa Relation

Theresa Relation

Auto-generated profile, based on publicly available information

Theresa Relation

Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2018 in Stem Cells
Verified
Journal Article
Open access
PDF file
TRTheresa Relation
Theresa Relation
TYTai Yi
Tai Yi
AGAdam J. Guess
Adam J. Guess
KPKrista La Perle
Krista La Perle
SOSatoru Otsuru
Satoru Otsuru
EHEdwin Horwitz
Edwin Horwitz
Neuroblastoma, the most common extracranial solid tumor in childhood, remains a therapeutic challenge. However, one promising patient treatment strategy is the delivery of anti‐tumor therapeutic agents via mesenchymal stromal cell (MSC) therapy. MSCs have been safely used to treat genetic bone diseases such as osteogenesis imperfecta, cardiovascular diseases, autoimmune diseases, and cancer. The pro‐inflammatory cytokine interferon‐gamma (IFNγ) has been shown to decrease tumor proliferation by altering the tumor microenvironment (TME). Despite this, clinical trials of systemic IFNγ therapy have failed due to the high blood concentration required and associated systemic toxicities. Here, we developed an intra‐adrenal model of neuroblastoma, characterized by liver and lung metastases. We then engineered MSCs to deliver IFNγ directly to the TME. In vitro, these MSCs polarized murine macrophages to the M1 phenotype. In vivo, we attained a therapeutically active TME concentration of IFNγ without increased systemic concentration or toxicity. The TME‐specific IFNγ reduced tumor growth rate and increased survival in two models of T cell deficient athymic nude mice. Absence of this benefit in NOD SCID gamma (NSG) immunodeficient mouse model indicates a mechanism dependent on the innate immune system. IL‐17 and IL‐23p19, both uniquely M1 polarization markers, transiently increased in the tumor interstitial fluid. Finally, the MSC vehicle did not promote tumor growth. These findings reveal that MSCs can deliver effective cytokine therapy directly to the tumor while avoiding systemic toxicity. This method transiently induces inflammatory M1 macrophage polarization, which reduces tumor burden in our novel neuroblastoma murine model. Stem Cells 2018;36:915–924

28 March 2017 in Stem Cells
Verified
Journal Article
Closed access
PDF file
TRTheresa Relation
Theresa Relation
MDMassimo Dominici
Massimo Dominici
EHEdwin M. Horwitz
Edwin M. Horwitz

26 March 2021 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
BOBridget A. Oppong
Bridget A. Oppong
SOSamilia Obeng-Gyasi
Samilia Obeng-Gyasi
TRTheresa Relation
Theresa Relation
LALucile Adams-Campbell
Lucile Adams-Campbell

5 May 2022 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
TRTheresa Relation
Theresa Relation
ANAmara Ndumele
Amara Ndumele
OBOindrila Bhattacharyya
Oindrila Bhattacharyya
JFJames L. Fisher
James L. Fisher
YLYaming Li
Yaming Li
BOBridget A. Oppong
Bridget A. Oppong

30 November 2021 in Surgery
Verified
Journal Article
Closed access
TRTheresa Relation
Theresa Relation
YLYaming Li
Yaming Li
JFJames L. Fisher
James L. Fisher
ATAllan Tsung
Allan Tsung
BOBridget A. Oppong
Bridget A. Oppong
SOSamilia Obeng-Gyasi
Samilia Obeng-Gyasi

14 February 2021 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
TRTheresa Relation
Theresa Relation
SOSamilia Obeng-Gyasi
Samilia Obeng-Gyasi
OBOindrila Bhattacharyya
Oindrila Bhattacharyya
YLYaming Li
Yaming Li
MEMariam F. Eskander
Mariam F. Eskander
BOBridget A. Oppong
Bridget A. Oppong